Friday 6 November 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue: +9.98%
EPS: +29.4%
Free cash flow: +6.21%
Total debt: −2.20%

Quarter to September 2026, against a year earlier

254.25 1.43 −0.56%

Follow DGX

Alert me

Market cap: $28.0B
P/E: 25.0×
Fwd P/E: 24.4×
Dividend yield: 1.33%
F-score: 8/9
Altman Z: 3.15
Beneish M: −2.65
Dividend safety: 85/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Quest Diagnostics Incorporated (DGX) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Quest Diagnostics Incorporated (DGX) trades at a price to free cash flow of 20.3×. Over the past ten years it has ranged from 7.6× (June 2021) to 26.5× (December 2023); the current reading is higher than 96% of that period. That is below the Diagnostics & Research industry median of 33.5× and in line with the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/DGX/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Quest Diagnostics Incorporated price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/DGX/metrics/price-to-free-cash-flow">Quest Diagnostics Incorporated (DGX) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	14.2×	(23.06%)
FY2024	18.4×	0.92%
FY2023	18.3×	32.75%
FY2022	13.8×	16.36%
FY2021	11.8×	17.45%
FY2020	10.1×	(40.72%)
FY2019	17.0×	22.46%
FY2018	13.9×	(5.57%)
FY2017	14.7×	(6.66%)
FY2016	15.7×	(14.34%)

Period	Price to free cash flow	Change
Sep 2026	18.6×	6.91%
Jun 2026	17.4×	7.27%
Mar 2026	16.3×	14.71%
Dec 2025	14.2×	(7.50%)
43 more quarters	Free account

Against its own ten years

Low 7.6× High 26.5×

Ten-year median 16.2×

Current reading's percentile 96

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated	20.3×
IQV IQVIA Holdings Inc. compare	21.0×
LH Labcorp Holdings Inc. compare	25.4×
MEDP Medpace Holdings, Inc. compare	26.6×
RVTY Revvity Inc. compare	28.2×
ILMN Illumina, Inc. compare	30.4×
MTD Mettler-Toledo International, Inc. compare	39.1×
WAT Waters Corporation compare	173×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Quest Diagnostics Incorporated (DGX) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on DGX

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on DGX

Stockrow Weekly